Run the business on answers the team trusts.

About two thirds of Commit is defensible. The rest is assertion.\n- **34% of Commit dollars have had no engagement activity in 14 days.** That's $4.11M of the $12.10M in Commit at Executive Level. Outbound-only activity doesn't count here; the test is whether the customer engaged back.\n- **Category isn't tracking engagement.** Nine deals sit in Commit with an engagement score below 40. Meridian is the largest at $512K, having fallen from 82 to 34 in thirty days without changing forecast category.\nThat second point is the one to carry into the forecast call. Commit is a rep's judgment, and nothing currently forces that judgment to move when the underlying engagement does.\nSo: the forecast isn't wrong, it's unevenly sourced. A third of it is asserted rather than evidenced, with no mechanism catching the difference.\nSources: 30 days of activity across 4 teams and 41 opportunities, through Sep 16.\n---\n[Show me the worst offenders by team]\nCommit dollars with no engagement activity in 14 days, by team.\n- **North America West —** $4.60M commit, $1.94M unevidenced (42%)\n- **EMEA —** $3.20M commit, $1.15M unevidenced (36%)\n- **North America East —** $2.85M commit, $0.71M unevidenced (25%)\n- **Key Accounts —** $1.45M commit, $0.31M unevidenced (21%)\nNorth America West is both the largest commit and the least evidenced, and it's the team closest to its number. Its three largest unevidenced deals — Meridian ($512K), Kestrel Marine ($455K), and Vantiv Rail ($325K) — all appear in the single-threading pattern too.

Unevidenced and single-threaded are mostly the same deals.

One gate is skipped routinely, and it's the one that predicts outcomes.\n- **41% of deals reaching Stage 4 — Proposal have no completed technical validation.** The gate exists in process and is not enforced in the system.\n- **Those deals win at 22%. Deals that complete it win at 58%.** Same stage, same categories, roughly two and a half times the win rate.\n- **Currently live: Pinnacle Rail Expansion sits in Stage 4 at $270K with no validation on record.** Meridian completed validation on Jul 9 but carries a blank Economic Buyer, so it clears one gate and fails another.\nSo: yes, it matters, and the cost is measurable. Validation is worth roughly 36 points of win rate and it's currently advisory.\nSources: 18 months of closed opportunities and 41 open, through Sep 16.\n---\n[Quantify the win rate impact]\n- **Technical validation —** skipped on 41% of Stage 4+ deals. Those win at 22% against 58% when completed, a 36-point gap.\n- **Named economic buyer —** missing on 29% of Commit. 31% against 54%, a 23-point gap.\n- **InfoSec review opened —** missing on 18% of Commit. 38% against 57%, a 19-point gap.\nApplied to current pipeline. $4.98M of open Commit and Best Case is sitting past a gate it never cleared. At the observed win rates, roughly $1.4M of expected value lost against what the same dollars would produce if the gates were enforced.

Caveat worth stating in the QBR: this is correlation on 18 months of history, not a controlled comparison.

$3.18M of the $4.72M in Best Case is blocked on something structural rather than on the customer's decision.\n- **Upside Without Executive Sponsorship — $1.68M, 6 opportunities.** No senior stakeholder identified at all. Ardent Biotech and Helix Diagnostics are the largest, both in validation.\n- **Stage Advanced Without Validation — $960K, 4 opportunities.** Moved to Proposal with the validation field empty. Pinnacle Rail Expansion anchors at $270K.\n- **No Activity in 30+ Days — $540K, 3 opportunities.** Westmark Utilities has been untouched 34 days while still carried as upside.\nSo: two thirds of best case isn't waiting on a buyer, it's waiting on us. These are process states, not customer states, which makes the number more recoverable than it looks and less real than it's being reported.\nSources: 30 days of activity across 14 Best Case opportunities, through Sep 16.\n---\n[Show me what's blocking it]\nUpside Without Executive Sponsorship — $1.68M across 6 opportunities.\n## Risk details\n- **Helix Diagnostics Platform ($410K, Delacroix) —** in Stage 3 — Validation with no contact above manager level on record.\n- **Ardent Biotech ($385K, Ashgrove) —** has no executive sponsor identified and a scorecard at 12.5%.\n## Next steps\n- Sponsorship requirement added to Best Case entry criteria, not just Commit.\n- Six opportunities flagged for the next pipeline call with their owning managers.\n## Pattern\n- Five of the six are new logos. The gap is in how new-logo deals are qualified on entry, not in how they're worked afterward.

An entry-criteria problem, so a process fix rather than a set of individual saves.

Backstory delivers robust

Read the AI buying guide

Book a demo

answers like this to revenue operations leaders just like you.

Book a demo and start winning more, even in complex selling motions.